This trial will test a new drug for adults with Generalized Anxiety Disorder - open to both men & women ages 18-65. Held at 50+ global sites, up to 12 week study.
- Generalized Anxiety Disorder
1 Primary · 1 Secondary · Reporting Duration: Week 8
Side Effects for
2 Treatment Groups
1 of 2
1 of 2
434 Total Participants · 2 Treatment Groups
Primary Treatment: SEP-363856 · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18 - 65 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|FutureSearch Trials of Dallas, LP||100.0%|
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Frequently Asked Questions
Is this trial allowing people of advanced age to be included?
"The current enrollment criteria stipulate that only those between the ages of 18 and 65 are eligible to participate." - Anonymous Online Contributor
How many participants are there in this trial?
"Confirmed. According to clinicaltrials.gov, the trial which went online on March 8th 2023 is presently searching for enrollees with 434 patients desired across 13 sites." - Anonymous Online Contributor
Is it possible to still join this investigation?
"As evidenced by the data on clinicaltrials.gov, enrolment for this medical study is currently open; its listing was posted and last updated on March 8th of 2023." - Anonymous Online Contributor
Where are the various locations hosting this research endeavor?
"Currently, 13 medical institutions are enrolling patients in this experiment. These sites span across Torrance, Tampa and Atlanta as well as several other places. To reduce travel time and costs associated with participation, it is wise to select a clinic near you when possible." - Anonymous Online Contributor
What requirements must I meet to participate in this research project?
"This medical trial is seeking 434 individuals with a DSM-5 diagnosis of Generalized Anxiety Disorder, aged from 18 to 65. To be accepted into the study, participants must fulfil certain requirements encompassing: gender specifications; an ability to comply with procedures and appointment schedules; as well as being able to comprehend verbal and written instructions." - Anonymous Online Contributor